THERALASE TECHNOLOGIES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.16 CAD | -3.03% |
|
0.00% | -8.57% |
| Apr. 24 | Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding | CI |
| Apr. 05 | Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent | CI |
Evolution of the average Target Price on Theralase Technologies Inc.
Price target over the last 5 years
History of analyst recommendation changes
b6b9d4b06d41657c4ea8dfdc5c4c0b._eWzBmgfD_sk_xs2MQh6LbRcaKvKAONtqmPSjV7C_UU.sIr-WV8uQoJnlFZ8X19MStA3Jt-6bYlYmimk32yEygGcsfBxA29Dy0GzLw~637ffea762ace8e89cf9d73aa535773a
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.16
CAD
Average target price
0.8
CAD
Spread / Average Target
+400.00%
High Price Target
0.8
CAD
Spread / Highest target
+400.00%
Low Price Target
0.8
CAD
Spread / Lowest Target
+400.00%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- TLT Stock
- Consensus Theralase Technologies Inc.
